Literature DB >> 33710310

BRCA1/2 and Endometrial Cancer Risk: Implications for Management.

Mark E Sherman1, William D Foulkes2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33710310      PMCID： PMC8418424          DOI： 10.1093/jnci/djab037

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  Response to Nahshon and Lavie.

Authors:  Cornelis D de Kroon; Marthe M de Jonge; Tjalling Bosse; Christi J van Asperen
Journal:  J Natl Cancer Inst       Date:  2022-02-07       Impact factor: 11.816

2.  RE: Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.

Authors:  Chen Nahshon; Ofer Lavie
Journal:  J Natl Cancer Inst       Date:  2022-02-07       Impact factor: 11.816

Review 3.  Risk-Reducing Options for High-Grade Serous Gynecologic Malignancy in BRCA1/2.

Authors:  Lauren Clarfield; Laura Diamond; Michelle Jacobson
Journal:  Curr Oncol       Date:  2022-03-21       Impact factor: 3.677
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.